Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins? (Q34107300)

31 July 2017

1 reference

title

Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins? (English)

1 reference

31 July 2017

1 reference

Faggiotto A

1

1 reference

31 July 2017

Paoletti R

series ordinal

2

1 reference

31 July 2017

1 January 2000

1 reference

Current Atherosclerosis Reports

31 July 2017

1 reference

31 July 2017

2

1 reference

31 July 2017

20-25

1 reference

31 July 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-000-0091-3

31 July 2017

0 references

cites work

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0091-3

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0091-3

Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0091-3

Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0091-3

Lovastatin induces apoptosis in malignant mesothelioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0091-3

Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0091-3

Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0091-3

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-000-0091-3

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

12 December 2020

Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

12 December 2020

Lovastatin induces p21WAF1/Cip1 in human vascular smooth muscle cells: influence on protein phosphorylation, cell cycle, induction of apoptosis, and growth inhibition.

1 reference

12 December 2020

Lovastatin prevents development of hypertension in spontaneously hypertensive rats

1 reference

12 December 2020

Inhibitor of proliferation of arterial smooth-muscle cells by fluvastatin

1 reference

12 December 2020

The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro

1 reference

12 December 2020

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells

1 reference

12 December 2020

Plaque instability--the real challenge for atherosclerosis research in the next decade?

1 reference

12 December 2020

A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme

1 reference

12 December 2020

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

1 reference

12 December 2020

Effects of lovastatin on the immune system

1 reference

12 December 2020

Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients

1 reference

12 December 2020

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

1 reference

12 December 2020

Hydrophilicity/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors

1 reference

12 December 2020

Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study

1 reference

12 December 2020

Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)

1 reference

12 December 2020

Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.

1 reference

12 December 2020

Human multidrug-resistant (MRP,p190) myeloid leukemia HL-60/ADR cells in vitro: resistance to the mevalonate pathway inhibitor lovastatin.

1 reference

12 December 2020

HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages

1 reference

12 December 2020

New insights into plaque stabilisation by lipid lowering.

1 reference

12 December 2020

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture

1 reference

12 December 2020

The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway

1 reference

12 December 2020

Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages

1 reference

12 December 2020

1 reference

12 December 2020

Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway

1 reference

12 December 2020

Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.

1 reference

12 December 2020

HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activation.

1 reference

12 December 2020

Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy

1 reference

12 December 2020

New insights into the pharmacodynamic and pharmacokinetic properties of statins.

1 reference

12 December 2020

The Otto Aufranc Award. Lovastatin prevents steroid induced adipogenesis and osteonecrosis.

1 reference

12 December 2020

Lovastatin maintains nitric oxide—but not EDHF-mediated endothelium-dependent relaxation in the hypercholesterolemic rabbit carotid artery

1 reference

12 December 2020

Chemotaxis of the monocyte cell line U937: Dependence on cholesterol and early mevalonate pathway products

1 reference

12 December 2020

Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: A potential therapeutic approach

1 reference

12 December 2020

Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.

1 reference

12 December 2020

In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.

1 reference

12 December 2020

Geranylgeraniol overcomes the block of cell proliferation by lovastatin in C6 glioma cells.

1 reference

12 December 2020

Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines

1 reference

12 December 2020

Direct vascular effects of HMG-CoA reductase inhibitors

1 reference

12 December 2020

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

1 reference

12 December 2020

Current and future treatment of hyperlipidemia: the role of statins

1 reference

12 December 2020

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

12 December 2020

Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as with wild-type K-ras oncogene but has different effects on protein phosphorylation and induction of apoptosis.

1 reference

12 December 2020

HMG-CoA reductase inhibitor-induced L6 myoblast cell death: involvement of the phosphatidylinositol 3-kinase pathway

1 reference

12 December 2020

10.1007/S11883-000-0091-3

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1026075431

0 references

Fatcat ID

release_ranx5nzuz5bytatiunvkhqknoi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ranx5nzuz5bytatiunvkhqknoi

24 November 2022

mapped directly with Wikidata item

1 reference